SLC22A12
MOLECULAR TARGETsolute carrier family 22 member 12
SLC22A12 (solute carrier family 22 member 12) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLC22A12
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | morin | 4.28 | 71 |
| 2 | mangostin | 4.14 | 62 |
| 3 | benzbromarone | 4.13 | 61 |
| 4 | fenofibric acid | 3.40 | 29 |
| 5 | lesinurad | 2.77 | 15 |
| 6 | pf 05089771 | 2.40 | 10 |
| 7 | benzarone | 2.20 | 8 |
| 8 | merbarone | 2.08 | 7 |
| 9 | dotinurad | 1.95 | 6 |
| 10 | Sulfinpyrazone | 0.69 | 1 |
About SLC22A12 as a Drug Target
SLC22A12 (solute carrier family 22 member 12) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented SLC22A12 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLC22A12 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.